PF-Atlas › Clinical Trials › NCT02679729

To Assess the Safety, Tolerability and Pharmacokinetics of AZD5634 Following Inhaled and Intravenous Dose Administration

AZD5634 for inhalation · Phase 1

Registry ID
NCT02679729
Phase
Phase 1
Status
Completed
Drug / intervention
AZD5634 for inhalation
Sponsor
AstraZeneca
Start
2016-02-11
Enrollment
63
Locations
2

About this trial

This is a Phase 1, first-in-human (FIH) single ascending dose study being conducted to better understand the safety, tolerability and pharmacokinetics of AZD5634 in healthy subjects

View NCT02679729 on ClinicalTrials.gov →

Explore related

All AZD5634 for inhalation trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT02679729 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.